Literature DB >> 3146972

Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.

C Masson1, E Angles-Cano.   

Abstract

The kinetics of inhibition of tissue-type plasminogen activator (t-PA) by the fast-acting plasminogen activator inhibitor-1 (PAI-1) was investigated in homogeneous (plasma) and heterogeneous (solid-phase fibrin) systems by using radioisotopic and spectrophotometric analysis. It is demonstrated that fibrin-bound t-PA is protected from inhibition by PAI-1, whereas t-PA in soluble phase is rapidly inhibited (K1 = 10(7) M-1.s-1) even in the presence of 2 microM-plasminogen. The inhibitor interferes with the binding of t-PA to fibrin in a competitive manner. As a consequence the Kd of t-PA for fibrin (1.2 +/- 0.4 nM) increases and the maximal velocity of plasminogen activation by fibrin-bound t-PA is not modified. From the plot of the apparent Kd versus the concentration of PAI-1 a Ki value of 1.3 +/- 0.3 nM was calculated. The quasi-similar values for the dissociation constants between fibrin and t-PA (Kd) and between PAI-1 and t-PA (Ki), as well as the competitive type of inhibition observed, indicate that the fibrinolytic activity of human plasma may be the result of an equilibrium distribution of t-PA between both the amount of fibrin generated and the concentration of circulating inhibitor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146972      PMCID: PMC1135393          DOI: 10.1042/bj2560237

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.

Authors:  P Wallén; B Wiman
Journal:  Biochim Biophys Acta       Date:  1972-01-26

3.  Differences in the binding to fibrin of urokinase and tissue plasminogen activator.

Authors:  S Thorsen; P Glas-Greenwalt; T Astrup
Journal:  Thromb Diath Haemorrh       Date:  1972-08-31

4.  Urokinase inhibitor in human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  Nature       Date:  1968-01-20       Impact factor: 49.962

5.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

6.  Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.

Authors:  A M Dosne; E Dupuy; E Bodevin
Journal:  Thromb Res       Date:  1978-03       Impact factor: 3.944

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.

Authors:  C Korninger; D Collen
Journal:  Thromb Haemost       Date:  1981-10       Impact factor: 5.249

9.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

Authors:  D C Rijken; D Collen
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  3 in total

1.  Modulation of fibrinolysis by ionizing radiation.

Authors:  J S Rao; A Rayford; M Yamamoto; K K Ang; P Tofilon; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.

Authors:  D Rouy; E Anglés-Cano
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

3.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.